BCL2 and hemorrhagic disease: The differentially expressed lncRNAs were significantly enriched in vaccinia and hemorrhagic diseases, biological processes of protein peptidyl-prolyl isomerization and peptidyl-proline modification, molecular functions of peptidyl-prolyl cis–trans isomerase activity and cis–trans isomerase activity, and cellular components of BIM–BCL–xl complex and BIM–BCL-2 complex (Figure 3C).